APO Research
Talk to an analyst

APO RESEARCH · REPORT

Newcastle Disease Vaccine

Newcastle disease is a contagious viral bird disease affecting many domestic and wild avian species; it is transmissible to humans.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Newcastle disease is a contagious viral bird disease affecting many domestic and wild avian species; it is transmissible to humans.

Newcastle disease can be controlled by the use of vaccines. There are many Newcastle disease vaccines suitable for use in commercial chickens.

Selected research

Industry Research

Newcastle Disease Vaccine Industry Research Report 2026

25 December 2025124 pages

Choose your research edition.

Industry ResearchNewcastle Disease Vaccine Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Newcastle Disease Vaccine Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Newcastle Disease Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Newcastle Disease Vaccine Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Newcastle Disease Vaccine Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

Newcastle disease is a contagious viral bird disease affecting many domestic and wild avian species; it is transmissible to humans.

Newcastle disease can be controlled by the use of vaccines. There are many Newcastle disease vaccines suitable for use in commercial chickens.

Market competition is intense. Merial, CEVA, QYH Biotech, Ringpu Biology and Yebio, etc. are the leader of this industry. They got about 63% market shares. Asia-Pacific is the largest consumption place, with a consumption market share nearly 56%. Following Asia-Pacific, North America is the second largest consumption place with the consumption market share of 2%.

Read the full market overview

Report Scope

This report quantifies the global Newcastle Disease Vaccine market in terms of revenue (US$ million) and, where applicable, sales volume (M Doses), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/M Doses) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Newcastle Disease Vaccine Market by Company

Merial

CEVA

QYH Biotech

Ringpu Biology

Yebio

Harbin Veterinary Research Institute

Merck Animal Health

DHN

Zoetis

ChengDu Tecbond

Elanco (Lohmann)

FATRO

CAVAC

Vaksindo

Newcastle Disease Vaccine Segment by Type

Live Vaccines

Killed Vaccines

Newcastle Disease Vaccine Segment by Application

Chicken

Duck & Goose

Other

Newcastle Disease Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Newcastle Disease Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Newcastle Disease Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Newcastle Disease Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Newcastle Disease Vaccine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Newcastle Disease Vaccine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Newcastle Disease Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Newcastle Disease Vaccine Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Newcastle Disease Vaccine Sales (M Doses) of Manufacturers (2021-2026) Table 7. Global Newcastle Disease Vaccine Sales Market Share by Manufacturers (2021-2026) Table 8. Global Newcastle Disease Vaccine Revenue of Manufacturers (2021-2026) Table 9. Global Newcastle Disease Vaccine Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Newcastle Disease Vaccine Average Price (USD/K Doses) of Manufacturers (2021-2026) Table 11. Global Newcastle Disease Vaccine Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Newcastle Disease Vaccine, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Newcastle Disease Vaccine, Product Type & Application Table 14. Global Newcastle Disease Vaccine Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Newcastle Disease Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Merial Company Information Table 19. Merial Business Overview Table 20. Merial Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 21. Merial Newcastle Disease Vaccine Product Portfolio Table 22. Merial Recent Developments Table 23. CEVA Company Information Table 24. CEVA Business Overview Table 25. CEVA Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 26. CEVA Newcastle Disease Vaccine Product Portfolio Table 27. CEVA Recent Developments Table 28. QYH Biotech Company Information Table 29. QYH Biotech Business Overview Table 30. QYH Biotech Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 31. QYH Biotech Newcastle Disease Vaccine Product Portfolio Table 32. QYH Biotech Recent Developments Table 33. Ringpu Biology Company Information Table 34. Ringpu Biology Business Overview Table 35. Ringpu Biology Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 36. Ringpu Biology Newcastle Disease Vaccine Product Portfolio Table 37. Ringpu Biology Recent Developments Table 38. Yebio Company Information Table 39. Yebio Business Overview Table 40. Yebio Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 41. Yebio Newcastle Disease Vaccine Product Portfolio Table 42. Yebio Recent Developments Table 43. Harbin Veterinary Research Institute Company Information Table 44. Harbin Veterinary Research Institute Business Overview Table 45. Harbin Veterinary Research Institute Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 46. Harbin Veterinary Research Institute Newcastle Disease Vaccine Product Portfolio Table 47. Harbin Veterinary Research Institute Recent Developments Table 48. Merck Animal Health Company Information Table 49. Merck Animal Health Business Overview Table 50. Merck Animal Health Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 51. Merck Animal Health Newcastle Disease Vaccine Product Portfolio Table 52. Merck Animal Health Recent Developments Table 53. DHN Company Information Table 54. DHN Business Overview Table 55. DHN Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 56. DHN Newcastle Disease Vaccine Product Portfolio Table 57. DHN Recent Developments Table 58. Zoetis Company Information Table 59. Zoetis Business Overview Table 60. Zoetis Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 61. Zoetis Newcastle Disease Vaccine Product Portfolio Table 62. Zoetis Recent Developments Table 63. ChengDu Tecbond Company Information Table 64. ChengDu Tecbond Business Overview Table 65. ChengDu Tecbond Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 66. ChengDu Tecbond Newcastle Disease Vaccine Product Portfolio Table 67. ChengDu Tecbond Recent Developments Table 68. Elanco (Lohmann) Company Information Table 69. Elanco (Lohmann) Business Overview Table 70. Elanco (Lohmann) Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 71. Elanco (Lohmann) Newcastle Disease Vaccine Product Portfolio Table 72. Elanco (Lohmann) Recent Developments Table 73. FATRO Company Information Table 74. FATRO Business Overview Table 75. FATRO Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 76. FATRO Newcastle Disease Vaccine Product Portfolio Table 77. FATRO Recent Developments Table 78. CAVAC Company Information Table 79. CAVAC Business Overview Table 80. CAVAC Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 81. CAVAC Newcastle Disease Vaccine Product Portfolio Table 82. CAVAC Recent Developments Table 83. Vaksindo Company Information Table 84. Vaksindo Business Overview Table 85. Vaksindo Newcastle Disease Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 86. Vaksindo Newcastle Disease Vaccine Product Portfolio Table 87. Vaksindo Recent Developments Table 88. Global Newcastle Disease Vaccine Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 89. Global Newcastle Disease Vaccine Sales by Region (2021-2026) & (M Doses) Table 90. Global Newcastle Disease Vaccine Sales Market Share by Region (2021-2026) Table 91. Global Newcastle Disease Vaccine Sales by Region (2027-2032) & (M Doses) Table 92. Global Newcastle Disease Vaccine Sales Market Share by Region (2027-2032) Table 93. Global Newcastle Disease Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 94. Global Newcastle Disease Vaccine Revenue Market Share by Region (2021-2026) Table 95. Global Newcastle Disease Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 96. Global Newcastle Disease Vaccine Revenue Market Share by Region (2027-2032) Table 97. North America Newcastle Disease Vaccine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 98. North America Newcastle Disease Vaccine Sales by Country (2021-2026) & (M Doses) Table 99. North America Newcastle Disease Vaccine Sales by Country (2027-2032) & (M Doses) Table 100. North America Newcastle Disease Vaccine Revenue by Country (2021-2026) & (US$ Million) Table 101. North America Newcastle Disease Vaccine Revenue by Country (2027-2032) & (US$ Million) Table 102. Europe Newcastle Disease Vaccine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 103. Europe Newcastle Disease Vaccine Sales by Country (2021-2026) & (M Doses) Table 104. Europe Newcastle Disease Vaccine Sales by Country (2027-2032) & (M Doses) Table 105. Europe Newcastle Disease Vaccine Revenue by Country (2021-2026) & (US$ Million) Table 106. Europe Newcastle Disease Vaccine Revenue by Country (2027-2032) & (US$ Million) Table 107. Asia Pacific Newcastle Disease Vaccine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 108. Asia Pacific Newcastle Disease Vaccine Sales by Country (2021-2026) & (M Doses) Table 109. Asia Pacific Newcastle Disease Vaccine Sales by Country (2027-2032) & (M Doses) Table 110. Asia Pacific Newcastle Disease Vaccine Revenue by Country (2021-2026) & (US$ Million) Table 111. Asia Pacific Newcastle Disease Vaccine Revenue by Country (2027-2032) & (US$ Million) Table 112. South America Newcastle Disease Vaccine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 113. South America Newcastle Disease Vaccine Sales by Country (2021-2026) & (M Doses) Table 114. South America Newcastle Disease Vaccine Sales by Country (2027-2032) & (M Doses) Table 115. South America Newcastle Disease Vaccine Revenue by Country (2021-2026) & (US$ Million) Table 116. South America Newcastle Disease Vaccine Revenue by Country (2027-2032) & (US$ Million) Table 117. Middle East and Africa Newcastle Disease Vaccine Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 118. Middle East and Africa Newcastle Disease Vaccine Sales by Country (2021-2026) & (M Doses) Table 119. Middle East and Africa Newcastle Disease Vaccine Sales by Country (2027-2032) & (M Doses) Table 120. Middle East and Africa Newcastle Disease Vaccine Revenue by Country (2021-2026) & (US$ Million) Table 121. Middle East and Africa Newcastle Disease Vaccine Revenue by Country (2027-2032) & (US$ Million) Table 122. Global Newcastle Disease Vaccine Sales by Type (2021-2026) & (M Doses) Table 123. Global Newcastle Disease Vaccine Sales by Type (2027-2032) & (M Doses) Table 124. Global Newcastle Disease Vaccine Sales Market Share by Type (2021-2026) Table 125. Global Newcastle Disease Vaccine Sales Market Share by Type (2027-2032) Table 126. Global Newcastle Disease Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 127. Global Newcastle Disease Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 128. Global Newcastle Disease Vaccine Revenue Market Share by Type (2021-2026) Table 129. Global Newcastle Disease Vaccine Revenue Market Share by Type (2027-2032) Table 130. Global Newcastle Disease Vaccine Price by Type (2021-2026) & (USD/K Doses) Table 131. Global Newcastle Disease Vaccine Price by Type (2027-2032) & (USD/K Doses) Table 132. Global Newcastle Disease Vaccine Sales by Application (2021-2026) & (M Doses) Table 133. Global Newcastle Disease Vaccine Sales by Application (2027-2032) & (M Doses) Table 134. Global Newcastle Disease Vaccine Sales Market Share by Application (2021-2026) Table 135. Global Newcastle Disease Vaccine Sales Market Share by Application (2027-2032) Table 136. Global Newcastle Disease Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 137. Global Newcastle Disease Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 138. Global Newcastle Disease Vaccine Revenue Market Share by Application (2021-2026) Table 139. Global Newcastle Disease Vaccine Revenue Market Share by Application (2027-2032) Table 140. Global Newcastle Disease Vaccine Price by Application (2021-2026) & (USD/K Doses) Table 141. Global Newcastle Disease Vaccine Price by Application (2027-2032) & (USD/K Doses) Table 142. Key Raw Materials Table 143. Raw Materials Key Suppliers Table 144. Newcastle Disease Vaccine Distributors List Table 145. Newcastle Disease Vaccine Customers List Table 146. Newcastle Disease Vaccine Industry Trends Table 147. Newcastle Disease Vaccine Industry Drivers Table 148. Newcastle Disease Vaccine Industry Restraints Table 149. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Newcastle Disease Vaccine Product Image Figure 5. Global Newcastle Disease Vaccine Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Newcastle Disease Vaccine Market Size (2021-2032) & (US$ Million) Figure 7. Global Newcastle Disease Vaccine Sales (2021-2032) & (M Doses) Figure 8. Global Newcastle Disease Vaccine Average Price (USD/K Doses) & (2021-2032) Figure 9. Live Vaccines Product Image Figure 10. Killed Vaccines Product Image Figure 11. Chicken Product Image Figure 12. Duck & Goose Product Image Figure 13. Other Product Image Figure 14. Global Newcastle Disease Vaccine Revenue Share by Manufacturers in 2025 Figure 15. Global Manufacturers of Newcastle Disease Vaccine, Manufacturing Sites & Headquarters Figure 16. Global Top 5 and 10 Newcastle Disease Vaccine Players Market Share by Revenue in 2025 Figure 17. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Newcastle Disease Vaccine Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 19. Global Newcastle Disease Vaccine Sales by Region in 2025 Figure 20. Global Newcastle Disease Vaccine Revenue by Region in 2025 Figure 21. North America Newcastle Disease Vaccine Market Size by Country in 2025 Figure 22. North America Newcastle Disease Vaccine Sales Market Share by Country (2021-2032) Figure 23. North America Newcastle Disease Vaccine Revenue Market Share by Country (2021-2032) Figure 24. United States Newcastle Disease Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 25. Canada Newcastle Disease Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Mexico Newcastle Disease Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Europe Newcastle Disease Vaccine Market Size by Country in 2025 Figure 28. Europe Newcastle Disease Vaccine Sales Market Share by Country (2021-2032) Figure 29. Europe Newcastle Disease Vaccine Revenue Market Share by Country (2021-2032) Figure 30. Germany Newcastle Disease Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. France Newcastle Disease Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. U.K. Newcastle Disease Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Italy Newcastle Disease Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Russia Newcastle Disease Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Spain Newcastle Disease Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Netherlands Newcastle Disease Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Switzerland Newcastle Disease Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Sweden Newcastle Disease Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Poland Newcastle Disease Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Asia Pacific Newcastle Disease Vaccine Market Size by Country in 2025 Figure 41. Asia Pacific Newcastle Disease Vaccine Sales Market Share by Country (2021-2032) Figure 42. Asia Pacific Newcastle Disease Vaccine Revenue Market Share by Country (2021-2032) Figure 43. China Newcastle Disease Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Japan Newcastle Disease Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. South Korea Newcastle Disease Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. India Newcastle Disease Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Australia Newcastle Disease Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Taiwan Newcastle Disease Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Southeast Asia Newcastle Disease Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Southeast Asia Newcastle Disease Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. South America Newcastle Disease Vaccine Market Size by Country in 2025 Figure 52. South America Newcastle Disease Vaccine Sales Market Share by Country (2021-2032) Figure 53. South America Newcastle Disease Vaccine Revenue Market Share by Country (2021-2032) Figure 54. Brazil Newcastle Disease Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Argentina Newcastle Disease Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Chile Newcastle Disease Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Colombia Newcastle Disease Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Middle East and Africa Newcastle Disease Vaccine Market Size by Country in 2025 Figure 59. Middle East and Africa Newcastle Disease Vaccine Sales Market Share by Country (2021-2032) Figure 60. Middle East and Africa Newcastle Disease Vaccine Revenue Market Share by Country (2021-2032) Figure 61. Egypt Newcastle Disease Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. South Africa Newcastle Disease Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. Israel Newcastle Disease Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. Türkiye Newcastle Disease Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. GCC Countries Newcastle Disease Vaccine Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. Global Newcastle Disease Vaccine Sales Market Share by Type (2021-2032) Figure 67. Global Newcastle Disease Vaccine Revenue Market Share by Type (2021-2032) Figure 68. Global Newcastle Disease Vaccine Price (USD/K Doses) by Type (2021-2032) Figure 69. Global Newcastle Disease Vaccine Sales Market Share by Application (2021-2032) Figure 70. Global Newcastle Disease Vaccine Revenue Market Share by Application (2021-2032) Figure 71. Global Newcastle Disease Vaccine Price (USD/K Doses) by Application (2021-2032) Figure 72. Newcastle Disease Vaccine Value Chain Figure 73. Newcastle Disease Vaccine Production Mode & Process Figure 74. Direct Comparison with Distribution Share Figure 75. Distributors Profiles Figure 76. Newcastle Disease Vaccine Industry Opportunities and Challenges

Scope & coverage.

Types
  • Live Vaccines
  • Killed Vaccines
Applications
  • Chicken
  • Duck & Goose
  • Other
Companies covered
  • Merial
  • CEVA
  • QYH Biotech
  • Ringpu Biology
  • Yebio
  • Harbin Veterinary Research Institute
  • Merck Animal Health
  • DHN
  • Zoetis
  • ChengDu Tecbond
  • Elanco (Lohmann)
  • FATRO
  • CAVAC
  • Vaksindo

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Newcastle Disease Vaccine Market Size (2021-2032)
  4. 2.2.2 Global Newcastle Disease Vaccine Sales (2021-2032)
  5. 2.2.3 Global Newcastle Disease Vaccine Market Average Price (2021-2032)
  6. 2.3 Newcastle Disease Vaccine by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Live Vaccines
  9. 2.3.3 Killed Vaccines
  10. 2.4 Newcastle Disease Vaccine by Application
  11. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  12. 2.4.2 Chicken
  13. 2.4.3 Duck & Goose
  14. 2.4.4 Other
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Newcastle Disease Vaccine Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Newcastle Disease Vaccine Sales (M Doses) of Manufacturers (2021-2026)
  3. 3.3 Global Newcastle Disease Vaccine Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Newcastle Disease Vaccine Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Newcastle Disease Vaccine Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Newcastle Disease Vaccine, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Newcastle Disease Vaccine, Product Type & Application
  8. 3.8 Global Manufacturers of Newcastle Disease Vaccine, Established Date
  9. 3.9 Global Newcastle Disease Vaccine Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Merial
  2. 4.1.1 Merial Company Information
  3. 4.1.2 Merial Business Overview
  4. 4.1.3 Merial Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Merial Newcastle Disease Vaccine Product Portfolio
  6. 4.1.5 Merial Recent Developments
  7. 4.2 CEVA
  8. 4.2.1 CEVA Company Information
  9. 4.2.2 CEVA Business Overview
  10. 4.2.3 CEVA Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 CEVA Newcastle Disease Vaccine Product Portfolio
  12. 4.2.5 CEVA Recent Developments
  13. 4.3 QYH Biotech
  14. 4.3.1 QYH Biotech Company Information
  15. 4.3.2 QYH Biotech Business Overview
  16. 4.3.3 QYH Biotech Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 QYH Biotech Newcastle Disease Vaccine Product Portfolio
  18. 4.3.5 QYH Biotech Recent Developments
  19. 4.4 Ringpu Biology
  20. 4.4.1 Ringpu Biology Company Information
  21. 4.4.2 Ringpu Biology Business Overview
  22. 4.4.3 Ringpu Biology Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Ringpu Biology Newcastle Disease Vaccine Product Portfolio
  24. 4.4.5 Ringpu Biology Recent Developments
  25. 4.5 Yebio
  26. 4.5.1 Yebio Company Information
  27. 4.5.2 Yebio Business Overview
  28. 4.5.3 Yebio Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Yebio Newcastle Disease Vaccine Product Portfolio
  30. 4.5.5 Yebio Recent Developments
  31. 4.6 Harbin Veterinary Research Institute
  32. 4.6.1 Harbin Veterinary Research Institute Company Information
  33. 4.6.2 Harbin Veterinary Research Institute Business Overview
  34. 4.6.3 Harbin Veterinary Research Institute Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Harbin Veterinary Research Institute Newcastle Disease Vaccine Product Portfolio
  36. 4.6.5 Harbin Veterinary Research Institute Recent Developments
  37. 4.7 Merck Animal Health
  38. 4.7.1 Merck Animal Health Company Information
  39. 4.7.2 Merck Animal Health Business Overview
  40. 4.7.3 Merck Animal Health Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Merck Animal Health Newcastle Disease Vaccine Product Portfolio
  42. 4.7.5 Merck Animal Health Recent Developments
  43. 4.8 DHN
  44. 4.8.1 DHN Company Information
  45. 4.8.2 DHN Business Overview
  46. 4.8.3 DHN Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 DHN Newcastle Disease Vaccine Product Portfolio
  48. 4.8.5 DHN Recent Developments
  49. 4.9 Zoetis
  50. 4.9.1 Zoetis Company Information
  51. 4.9.2 Zoetis Business Overview
  52. 4.9.3 Zoetis Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Zoetis Newcastle Disease Vaccine Product Portfolio
  54. 4.9.5 Zoetis Recent Developments
  55. 4.10 ChengDu Tecbond
  56. 4.10.1 ChengDu Tecbond Company Information
  57. 4.10.2 ChengDu Tecbond Business Overview
  58. 4.10.3 ChengDu Tecbond Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 ChengDu Tecbond Newcastle Disease Vaccine Product Portfolio
  60. 4.10.5 ChengDu Tecbond Recent Developments
  61. 4.11 Elanco (Lohmann)
  62. 4.11.1 Elanco (Lohmann) Company Information
  63. 4.11.2 Elanco (Lohmann) Business Overview
  64. 4.11.3 Elanco (Lohmann) Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Elanco (Lohmann) Newcastle Disease Vaccine Product Portfolio
  66. 4.11.5 Elanco (Lohmann) Recent Developments
  67. 4.12 FATRO
  68. 4.12.1 FATRO Company Information
  69. 4.12.2 FATRO Business Overview
  70. 4.12.3 FATRO Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 FATRO Newcastle Disease Vaccine Product Portfolio
  72. 4.12.5 FATRO Recent Developments
  73. 4.13 CAVAC
  74. 4.13.1 CAVAC Company Information
  75. 4.13.2 CAVAC Business Overview
  76. 4.13.3 CAVAC Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 CAVAC Newcastle Disease Vaccine Product Portfolio
  78. 4.13.5 CAVAC Recent Developments
  79. 4.14 Vaksindo
  80. 4.14.1 Vaksindo Company Information
  81. 4.14.2 Vaksindo Business Overview
  82. 4.14.3 Vaksindo Newcastle Disease Vaccine Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Vaksindo Newcastle Disease Vaccine Product Portfolio
  84. 4.14.5 Vaksindo Recent Developments
5 Global Newcastle Disease Vaccine Market Scenario by Region
  1. 5.1 Global Newcastle Disease Vaccine Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Newcastle Disease Vaccine Sales by Region: 2021-2032
  3. 5.2.1 Global Newcastle Disease Vaccine Sales by Region: 2021-2026
  4. 5.2.2 Global Newcastle Disease Vaccine Sales by Region: 2027-2032
  5. 5.3 Global Newcastle Disease Vaccine Revenue by Region: 2021-2032
  6. 5.3.1 Global Newcastle Disease Vaccine Revenue by Region: 2021-2026
  7. 5.3.2 Global Newcastle Disease Vaccine Revenue by Region: 2027-2032
  8. 5.4 North America Newcastle Disease Vaccine Market Facts & Figures by Country
  9. 5.4.1 North America Newcastle Disease Vaccine Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Newcastle Disease Vaccine Sales by Country (2021-2032)
  11. 5.4.3 North America Newcastle Disease Vaccine Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Newcastle Disease Vaccine Market Facts & Figures by Country
  16. 5.5.1 Europe Newcastle Disease Vaccine Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Newcastle Disease Vaccine Sales by Country (2021-2032)
  18. 5.5.3 Europe Newcastle Disease Vaccine Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Newcastle Disease Vaccine Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Newcastle Disease Vaccine Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Newcastle Disease Vaccine Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Newcastle Disease Vaccine Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Newcastle Disease Vaccine Market Facts & Figures by Country
  41. 5.7.1 South America Newcastle Disease Vaccine Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Newcastle Disease Vaccine Sales by Country (2021-2032)
  43. 5.7.3 South America Newcastle Disease Vaccine Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.7.7 Colombia
  48. 5.8 Middle East and Africa Newcastle Disease Vaccine Market Facts & Figures by Country
  49. 5.8.1 Middle East and Africa Newcastle Disease Vaccine Market Size by Country: 2021 VS 2025 VS 2032
  50. 5.8.2 Middle East and Africa Newcastle Disease Vaccine Sales by Country (2021-2032)
  51. 5.8.3 Middle East and Africa Newcastle Disease Vaccine Revenue by Country (2021-2032)
  52. 5.8.4 Egypt
  53. 5.8.5 South Africa
  54. 5.8.6 Israel
  55. 5.8.7 Türkiye
  56. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Newcastle Disease Vaccine Sales by Type (2021-2032)
  2. 6.1.1 Global Newcastle Disease Vaccine Sales by Type (2021-2032) & (M Doses)
  3. 6.1.2 Global Newcastle Disease Vaccine Sales Market Share by Type (2021-2032)
  4. 6.2 Global Newcastle Disease Vaccine Revenue by Type (2021-2032)
  5. 6.2.1 Global Newcastle Disease Vaccine Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Newcastle Disease Vaccine Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Newcastle Disease Vaccine Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Newcastle Disease Vaccine Sales by Application (2021-2032)
  2. 7.1.1 Global Newcastle Disease Vaccine Sales by Application (2021-2032) & (M Doses)
  3. 7.1.2 Global Newcastle Disease Vaccine Sales Market Share by Application (2021-2032)
  4. 7.2 Global Newcastle Disease Vaccine Revenue by Application (2021-2032)
  5. 7.2.1 Global Newcastle Disease Vaccine Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Newcastle Disease Vaccine Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Newcastle Disease Vaccine Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Newcastle Disease Vaccine Value Chain Analysis
  2. 8.1.1 Newcastle Disease Vaccine Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Newcastle Disease Vaccine Production Mode & Process
  5. 8.2 Newcastle Disease Vaccine Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Newcastle Disease Vaccine Distributors
  8. 8.2.3 Newcastle Disease Vaccine Customers
9 Global Newcastle Disease Vaccine Analyzing Market Dynamics
  1. 9.1 Newcastle Disease Vaccine Industry Trends
  2. 9.2 Newcastle Disease Vaccine Industry Drivers
  3. 9.3 Newcastle Disease Vaccine Industry Opportunities and Challenges
  4. 9.4 Newcastle Disease Vaccine Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst